UPG-111
UPG-111 is a peptide compound that acts as a negative allosteric modulator of the Urotensin II receptor (UTR). UPG-111 exhibits a dual inhibitory effect on the vasoconstriction induced by UTR agonists - it reduces both the maximum response intensity and the sensitivity of the agonist. UPG-111 does not induce calcium release or cause contraction of the endothelium-deprived rat aortic rings. UPG-111 can be used for the study of various diseases related to the angiotensinergic system.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 3090687-02-5
- 分子式: C64H87N13O17S2
- 分子量:1374.58
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
化学情報
-
CAS 番号 3090687-02-5
-
分子量 1374.58
-
分子式 C64H87N13O17S2
-
配列
{hSer}-{TPED}-{Pen}-Phe-{d-Trp}-{Orn}-Tyr-Cys-Val (Disulfide bridge: Pen-Cys)
-
シーケンスの短縮
{hSer}-{TPED}-{Pen}-F-{d-Trp}-{Orn}-YCV (Disulfide bridge: Pen-Cys)
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
- UPG-111
- 3090687-02-5
- UPG111
- UPG 111
- Urotensin Receptor
- Urotensin II receptor (UTR) modulators
- Negative allosteric modulator (NAM)
- Lateral allostery
- GPCR multimeric model
- Structure-activity relationship (SAR)
- N-terminal peptide engineering
- Noncompetitive antagonism
- Calcium mobilization
- Rat aorta contraction
- Inhibitor
- inhibitor
- inhibit